Continuous Diligence · v2.6

The research desk for early-stage investors.

Partners see 2,000 decks a year, meet 200, invest in 10. 33X runs a swarm of research agents across every live UK early-stage deal — so the filter isn't gut feel, it's evidence.

Every claim source-linked Deterministic scoring Versioned memos
147+
Deals covered
8.4k
Sources linked
24/7
Agent watch
2,813
Memo versions
Workstation · NovaPay
Live
NovaPay
Seed · Fintech · UK · EIS
v12 · 14s ago
Swarm
Extract Financials Source Cohort
· 4 active
Framework Assessment
Structural
Strong
Valuation
Market
Capital
Sufficient
Execution
Medium
Confidence
Medium
[source] Matched claim to Pitch Deck p.1402s
[cohort] Rebenched vs Fintech Seed '2407s
[stress] Runway scenario −15% revenue: pass14s
Continuous Diligence
NovaPay+2 ptsStructuralNorthforgere-scored v4CapitalLumenpathnew sourceClinicalTidepool−1 ptExecutionKelvincorev2 releasedMemoHalcyoncohort shiftValuationForgewave+3 ptsStructuralArborynnew filingLegalMeridianstress failSurvivabilityPolaris+1 ptConfidenceNovaPay+2 ptsStructuralNorthforgere-scored v4CapitalLumenpathnew sourceClinicalTidepool−1 ptExecutionKelvincorev2 releasedMemoHalcyoncohort shiftValuationForgewave+3 ptsStructuralArborynnew filingLegalMeridianstress failSurvivabilityPolaris+1 ptConfidence

— Configuration

One platform.
Three ways to use it.

Not three products — three named points on one research engine. Choose deal visibility, public profile, and thesis customization independently.

01
Live

Reader

Independent research, on every deal.

Configured for
VisibilityON
Profile
Thesis
  • Public memos
  • Watchlist
  • Version alerts
Start reading
02
Roadmap 2026

Syndicate

A standing IC meeting — and a front door for new members.

Configured for
VisibilityON
ProfileON
Thesis
  • Private workspace
  • Thesis-weighted scoring
  • Public profile for member acquisition
Join the wait-list
03
Live

Fund

Your own continuous-diligence engine, tuned to your thesis.

Configured for
VisibilityON
ProfileON
ThesisON
  • Private instance
  • Custom modules
  • Portfolio tracking
  • Agent-API
Book a demo

The Thesis

Due diligence isn't a moment. It's a process that never ends.

Most research stops the day the memo ships. 33X keeps reviewing — every new filing, every funding round, every claim you care about — so the record stays true to the facts.

Continuous review

A research swarm watches every covered deal. When source documents, financial filings, or market signals change materially, a new memo version is released within hours — not quarters.

Evidence, not opinion

Every claim in every memo is linked to its origin — pitch deck page, filing section, or market data point. Click any underlined statement to see the source.

The record compounds

Memos are versioned and timestamped. Nothing overwrites. You see exactly what we knew, when we knew it, and why our view changed.

extract
cohort
source
stress
memo
watch
NovaPay
Under review

Every Claim, Sourced

Click any statement. See the document it came from.

No unsupported claims. No “according to management.” Every number, every trajectory, every thesis point traces back to a specific source — exactly as the swarm found it.

Memo excerpt · v12

NovaPay has demonstrated GMV growth of 3.8× over twelve months[1], materially outpacing the fintech seed cohort median of 14% MoM[3]. Stress-testing runway against a −15% revenue scenario, the cash position of £812k[2] supports 14 months of operation at current burn — sufficient to reach the next milestone under base and stressed paths.

— Confidence: Medium · Last reviewed 14s ago by source-agent

Provenance
1Pitch Deck v3 · p.14

Monthly GMV reached £1.2m in October 2025, 3.8× the January 2025 baseline.

2Companies House · AA01

Cash position of £812,440 reported as of filing date 31-Dec-2025.

3Cohort Benchmark · Fintech Seed '24

Median MoM growth for UK Fintech Seed (n=42) was 14% over the trailing 12 months.

Featured Research

Latest Coverage

View all coverage
NovaPay
Seed · Fintech
Live · under review
FintechUK · EISv12
Raise
£1.5m
Valuation
£6.4m
Runway
21mo
Score
6/8
Northforge
Pre-Seed · Climate Tech
Watching
Climate TechUK · SEISv5
Raise
£250k
Valuation
£3.1m
Runway
14mo
Score
5/8
Lumenpath
Seed+ · Health Tech
Live · under review
Health TechUK · EISv8
Raise
£2.8m
Valuation
£9.8m
Runway
18mo
Score
7/8

How 33X Works

Three stages. Running continuously.

01

Extract

Swarm agents ingest pitch decks, filings, market data, and founder communications — parsing each into structured, source-linked claims.

ingestion · parsing · claim extraction
02

Stress

Deterministic scenarios — burn expansion, revenue miss, timing delay — benchmarked against live stage and sector cohorts.

scenarios · cohorts · confidence bands
03

Version

Every material change triggers a new memo version. The record compounds. Nothing overwrites. The audit trail is complete.

watch · diff · version · publish

Access

Membership

Member-funded independent research. Full memo history, source links, and continuous version alerts.

Reader

Individual
£29/month

For individual angels and EIS investors tracking the market.

  • Public memo summaries
  • Coverage index across live deals
  • Watchlist with basic alerts
Start reading

Member

£500–£1,000/mo
£1,000£500/month · founding

For pro investors, small funds, and syndicate leads running real checks.

  • Full memo history, every version
  • Source-linked evidence on every claim
  • Stress-test scenarios + cohort benchmarks
  • Drift alerts on tracked deals
  • Bi-weekly calibration call
Join as a Member
33X — Continuous Diligence for UK Early-Stage